|
Data Collection in Women with Fabry Disease Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Data Collection in Women with Fabry Disease conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Data Collection in Women with Fabry Disease Clinical research trials and Data Collection in Women with Fabry Disease health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Data Collection in Women with Fabry Disease. Data Collection in Women with Fabry Disease Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Data Collection in Women with Fabry Disease clinical trial. Test subjects typically receive the most expert healthcare available for their Data Collection in Women with Fabry Disease condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Data Collection in Women with Fabry Disease  Data Collection in Women with Fabry Disease
Data Collection in Women with Fabry Disease
For Condition: Fabry Disease
Status: Completed
Sponsor(s): National Institute of Neurological Disorders and Stroke (NINDS) ,
Synopsis: This protocol will collect information needed to design a clinical study for the symptoms and problems of women with Fabry disease, an inherited metabolic disorder. In this disease, an enzyme called a-galactosidase A, which normally breaks down fatty substances called glycolipids, does not function properly. The resulting accumulation of glycolipids in various tissues causes arm and leg pain, skin lesions, and problems with the kidneys, heart, nerves, and blood vessels. This protocol does not involve any experimental drug treatments, but participants may be offered enrollment in future studies and registries. Women 18 years of age and older with Fabry disease who have not had enzyme replacement therapy may participate in this study. Pregnant women are eligible, but may be excluded from certain procedures, such as magnetic resonance imaging (MRI). Participants will have the following tests and procedures over a 3-day period: - Personal and family medical history - Physical, neurological, and eye examinations - Blood and urine tests - Electrocardiogram (ECG) to measure electrical activity of the heart - Echocardiogram (ultrasound) to examine the heart muscles and pumping action - Magnetic resonance imaging (MRI) to examine the brain. This test uses a magnetic field and radio waves to produce images of the brain. The patient lies in a narrow cylinder (the MRI scanner) during the imaging and may talk with staff at any time during the procedure. - Magnetic resonance angiogram (MRA) to examine the blood vessels in the head and neck. This procedure is similar to MRI. - Genotyping to confirm the diagnosis of Fabry disease. DNA from a blood sample will be examined for the gene associated with Fabry disease. - Skin punch biopsy for microscopic examination of tissue. A piece of skin tissue about 1/8-inch thick is removed with a cookie cutter-like instrument. Participants will also complete two questionnaires regarding pain and quality of life. They will be asked to stop taking pain medications for 7 days before completing the pain questionnaire, but may resume medications before 7 days if the pain is too intense. The questionnaire will be completed by telephone interview. Patients will also be asked to keep a diary of pain medications taken for 7 days while on the study.
Details: This is a study to collect normative data in female patients with Fabry disease. After signing informed consent, patients will complete various study evaluations. Serious adverse events will be monitored throughout the patients study participation (approximately 7 days).
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Female
Protocol Entry Criteria: The patient must provide written informed consent prior to any study-related procedures being performed. Patients must be 18 years of age or older. Patients must have signs of symptoms consistent with Fabry disease with no prior treatment with any enzyme replacement therapy for Fabry Disease. Patients of childbearing potential must have a negative pregnancy test (urine beta-hCG) in order to complete all study tests. If a patient is pregnant, they may still enter the trial but may not participate in MRI or MRA procedures. Patients who have received an investigational drug within 30 days prior to study enrollment or received prior treatment with any enzyme replacement therapy for Fabry disease will be excluded. Patients who have diabetic nephropathy or other confounding renal disorder will be excluded. Patients who have a clinically significant organic disease or an unstable condition that, in the opinion of the Investigator, would preclude participation in this protocol will be excluded.
Total Enrollment: 60
Location and Contact Information:
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 020116; 02-N-0116
Study Start Date: January 31, 2002
Record last reviewed: February 19, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00030134
Other Fabry Disease Studies:
1. A Study of Fabrazyme in Pediatric Patients with Fabry Disease
2. Alpha-Galactosidase A Replacement Therapy for Fabry Disease
3. Vasodilation in Patients with Fabry's Disease
4. Registry of Fabry Disease - A Multicenter Observational Study
5. Dosing Study of Replagal in Patients with Fabry Disease
Related Studies:
Other Fabry Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Data Collection in Women with Fabry Disease
|
|
|
|
|
|
|
|
